Hepatitis B virus (HBV) is a partially double stranded DNA virus with genetic diversity represented by eight genotypes (A to H). Natural course and response to treatment could be affected by HBV genotypes. HBV shows high rates of turn over in the absence of proof-reading ability. As a result, large amounts of quasi-species are produced naturally or antiviral-associated. HBV consists of four open reading frames, namely preS/S gene, precore/core gene, polymerase gene, and X gene. Mutations on preS gene can result in undetectable HBsAg even in case that HBV is replicating. Surface gene mutation leads to decreased binding affinity to anti-HBs, which is associated with a vaccine escape mutant. Precore mutation abolishes HBeAg whereas mutations on basal core promoter gene down-regulate the HBeAg production. Mutations on basal core promoter are associated with increased HBV replication and high incidence of progressive liver diseases such as liver cirrhosis and hepatocellular carcinoma. Mutations on polymerase genes are often induced by antiviral therapy. Emergence of antiviral-resistant mutation is the major cause of treatment failure. Furthermore, existence of prior antiviral-resistant mutations limits the options of subsequent antiviral agents. Therefore, judicious use of antivirals and selection of the most potent drug with the lowest resistance rate are of the utmost importance for the prevention of antiviral-associated mutants. Detailed knowledge and understanding of HBV genetic diversity and mutant would be critical to establish strategies for the diagnosis and management of HBV infection. (Korean J Hepatol 2008;14:446-464)
Molecular characterization of hepatitis B virus among chronic hepatitis B patients from Pointe Noire, Republic of Congo Brunel Monic Angounda, Gildas Hoffman Ngouloubi, Amélia Bokilo Dzia, Luc Magloire Anicet Boumba, Warda Baha, Donatien Moukassa, Gabriel Ahombo, Moulay Mustapha Ennaji, Jean-Rosaire Ibara Infectious Agents and Cancer.2016;[Epub] CrossRef
Long-Term Outcomes and Dynamics of Mutants Associated with Lamivudine-Adefovir Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B Jihyun Kim, Sae Hwan Lee, Hong Soo Kim, Kanghyug Choi, Soung Won Jeong, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Boo Sung Kim Gut and Liver.2015; 9(1): 103. CrossRef
Current and future antiviral drug therapies of hepatitis B chronic infection Lemonica Koumbi World Journal of Hepatology.2015; 7(8): 1030. CrossRef
Analysis of Reverse Transcriptase Gene Mutations in the Hepatitis B Virus at a University Hospital in Korea A-Jin Lee, Chang Hyeong Lee, Chang-Ho Jeon Annals of Laboratory Medicine.2014; 34(3): 230. CrossRef
Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade Hyung Joon Yim, Seong Gyu Hwang Clinical and Molecular Hepatology.2013; 19(3): 195. CrossRef
Adding adefovir vs. switching to entecavir for lamivudine‐resistant chronic hepatitis B (ACE study): a 2‐year follow‐up randomized controlled trial Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Chang Wook Kim, Chang Don Lee, Sang Hoon Park, Myung Seok Lee, Choong Kee Park, Hee Bok Chae, Moon Young Kim, Soon Koo Baik, Yun Soo Kim, Ju Hyun Kim, Jung Il Lee, Jin Woo Lee, Sun Pyo Hong, Soon Ho Um Liver International.2013; 33(2): 244. CrossRef
Molecular epidemiological study of hepatitis B virus in blood donors from five Chinese blood centers Yu Liu, Jingxing Wang, Yi Huang, Tonghan Yang, Xiaoming Guo, Julin Li, Guoxin Wen, Zhongqiao Yun, Peibin Zeng, Miao He, Min Xu, Gui Liu, Ling Ke, David Wright, Jing Liu, Kenrad Nelson, Hua Shan Archives of Virology.2012; 157(9): 1699. CrossRef
A natural mutation of the hepatitis B virus X gene affects cell cycle progression and apoptosis in Huh7 cells Chang Hee Yang, Byung-Cheol Song, Moonjae Cho Journal of the Korean Society for Applied Biological Chemistry.2012; 55(2): 229. CrossRef
Suppression of Hepatitis B Virus X Protein-Mediated Tumorigenic Effects by Ursolic Acid Hong-Yin Wu, Chi-I Chang, Bo-Wei Lin, Feng-Ling Yu, Ping-Yuan Lin, Jue-Liang Hsu, Chia-Hung Yen, Ming-Huei Liao, Wen-Ling Shih Journal of Agricultural and Food Chemistry.2011; 59(5): 1713. CrossRef
